Shockwave Medical Debuts Enhanced Catheter at TCT 2023, Announces Clinical Research Validation
Debuting its C2+ Catheter in the United States during the recent Transcatheter Cardiovascular Therapeutics conference, TCT 2023, Shockwave Medical, Inc. also recently announced new Shockwave Coronary IVL publications have confirmed the safety and efficacy across multiple calcium morphologies.
Source: dicardiology.com